Latest Period
Q1 2026
Security Snapshot
Anika Therapeutics, Inc. - Common Stock (ANIK) Institutional Ownership
CUSIP: 035255108
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
128
Shares (Excl. Options)
12,358,601
Price
$14.50
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- ANIK on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 12,358,601
- Total 13F value
- $179,052,144
- Portfolio coverage rank
- 0%
- Share change
- +165,340
- Value change
- +$4,742,579
- Number of holders
- 128
- Shares outstanding
- 13,404,566
- SEC-reported price per share
- $14.54
- Insider filing price
- $14.54
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ANIK - Anika Therapeutics, Inc. - Common Stock is tracked under CUSIP 035255108.
- 128 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 126 to 128 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $117,480,288 to $179,052,144.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 128 institutions filings for Q1 2026.
Security key
035255108
Latest holder period
Q1 2026
13F holders
128
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
ANIK full holder history
Anika Therapeutics, Inc. SEC filings
Anika Therapeutics, Inc. company facts
Anika Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 035255108:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
ANIK
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Caligan Partners LP | 10% | 0% | $13,791,743 | 1,435,130 | 0% | Caligan Partners LP | 23 Jan 2026 | |
| BlackRock, Inc. | 6.8% | -35% | $14,147,616 | -$8,737,671 | 963,078 | -38% | BlackRock, Inc. | 31 Mar 2025 |
| BlackRock Portfolio Management LLC | 5.5% | $7,454,957 | 793,359 | BlackRock Portfolio Management LLC | 30 Sep 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.2% | $10,088,024 | 695,697 | Vanguard Capital Management | 31 Mar 2026 | |||
| DIMENSIONAL FUND ADVISORS LP | 4.5% | $9,656,545 | 657,355 | Dimensional Fund Advisors LP | 31 Dec 2024 | |||
| Trigran Investments, Inc. | 1.2% | -91% | $1,618,745 | -$13,965,184 | 168,400 | -90% | Trigran Investments, Inc. | 31 Dec 2025 |
As of 31 Mar 2026, 128 institutional investors reported holding 12,358,601 shares of Anika Therapeutics, Inc. - Common Stock (ANIK). This represents 92% of the company’s total 13,404,566 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
77%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | 1,594,893 | -3.6% | 0% | $23,125,950 |
| Caligan Partners LP | 11% | 1,435,130 | 0% | 1.5% | $20,809,385 |
| MORGAN STANLEY | 6.5% | 872,066 | +13% | 0% | $12,644,959 |
| ACADIAN ASSET MANAGEMENT LLC | 4.5% | 606,544 | 0% | 0.01% | $8,789,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 605,777 | 0% | 0% | $8,783,767 |
| BOOTHBAY FUND MANAGEMENT, LLC | 4% | 529,503 | -0.94% | 0.18% | $7,677,794 |
| RENAISSANCE TECHNOLOGIES LLC | 3.7% | 502,217 | -2.6% | 0.01% | $7,282,147 |
| DIMENSIONAL FUND ADVISORS LP | 3.4% | 458,847 | -7.2% | 0% | $6,653,069 |
| CAPITAL MANAGEMENT CORP /VA | 3.3% | 447,721 | -11% | 1.1% | $6,491,947 |
| DEUTSCHE BANK AG\ | 2.6% | 353,174 | +334% | 0% | $5,121,023 |
| STATE STREET CORP | 2.6% | 346,092 | +2.8% | 0% | $5,018,334 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5% | 330,051 | +1.4% | 0% | $4,787,275 |
| AQR CAPITAL MANAGEMENT LLC | 2% | 272,269 | +293% | 0% | $3,947,901 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2% | 265,627 | +36% | 0.02% | $3,851,592 |
| TWO SIGMA INVESTMENTS, LP | 1.8% | 236,120 | +0.99% | 0% | $3,423,740 |
| D. E. Shaw & Co., Inc. | 1.7% | 229,796 | -23% | 0% | $3,332,042 |
| GOLDMAN SACHS GROUP INC | 1.6% | 217,878 | +32% | 0% | $3,159,232 |
| AMERICAN CENTURY COMPANIES INC | 1% | 137,584 | +37% | 0% | $1,994,968 |
| UBS Group AG | 0.99% | 133,074 | +366% | 0% | $1,929,574 |
| Quantinno Capital Management LP | 0.94% | 125,826 | +24% | 0% | $1,824,477 |
| Man Group plc | 0.93% | 124,293 | +93% | 0% | $1,802,249 |
| Nuveen, LLC | 0.9% | 120,717 | +127% | 0% | $1,750,398 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.85% | 114,399 | +7.6% | 0% | $1,658,786 |
| NORTHERN TRUST CORP | 0.83% | 111,836 | +0.11% | 0% | $1,621,623 |
| ENVESTNET ASSET MANAGEMENT INC | 0.82% | 110,096 | -6.6% | 0% | $1,596,392 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 12,358,601 | $179,052,144 | +$4,742,579 | $14.50 | 128 |
| 2025 Q4 | 12,225,291 | $117,480,288 | +$240,095 | $9.61 | 126 |
| 2025 Q3 | 12,231,336 | $114,982,408 | -$5,970,888 | $9.40 | 114 |
| 2025 Q2 | 12,685,136 | $134,203,655 | -$1,529,085 | $10.58 | 101 |
| 2025 Q1 | 12,677,819 | $190,700,837 | +$2,180,082 | $15.03 | 107 |
| 2024 Q4 | 12,529,691 | $206,235,517 | -$14,093,626 | $16.46 | 108 |
| 2024 Q3 | 13,093,708 | $323,524,735 | -$7,569,530 | $24.70 | 121 |
| 2024 Q2 | 13,238,350 | $335,327,792 | -$3,265,667 | $25.33 | 113 |
| 2024 Q1 | 13,404,303 | $340,492,164 | +$4,319,363 | $25.40 | 119 |
| 2023 Q4 | 13,250,118 | $300,245,422 | +$6,673,700 | $22.66 | 116 |
| 2023 Q3 | 13,003,869 | $242,256,970 | -$5,557,577 | $18.63 | 116 |
| 2023 Q2 | 13,100,461 | $340,372,426 | +$436,229 | $25.98 | 116 |
| 2023 Q1 | 13,079,037 | $375,621,420 | -$1,049,447 | $28.72 | 118 |
| 2022 Q4 | 13,106,170 | $387,952,547 | -$23,669,010 | $29.60 | 123 |
| 2022 Q3 | 13,466,221 | $320,512,893 | -$1,527,070 | $23.80 | 114 |
| 2022 Q2 | 13,537,892 | $302,166,866 | -$732,634 | $22.32 | 118 |
| 2022 Q1 | 13,595,480 | $341,424,225 | +$996,762 | $25.11 | 114 |
| 2021 Q4 | 13,487,182 | $483,258,995 | +$10,255,331 | $35.83 | 125 |
| 2021 Q3 | 13,151,662 | $559,519,170 | -$490,889 | $42.56 | 127 |
| 2021 Q2 | 13,141,807 | $568,895,445 | -$4,270,965 | $43.29 | 133 |
| 2021 Q1 | 13,310,684 | $543,030,178 | -$15,429,177 | $40.79 | 144 |
| 2020 Q4 | 13,538,757 | $612,639,033 | +$244,003 | $45.26 | 156 |
| 2020 Q3 | 13,592,200 | $481,004,726 | -$8,432,726 | $35.39 | 153 |
| 2020 Q2 | 13,813,202 | $520,292,852 | +$34,612,076 | $37.73 | 155 |
| 2020 Q1 | 13,000,312 | $375,884,789 | -$23,630,047 | $28.91 | 160 |